You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-APOBEC3G antibody (ab54257)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-APOBEC3G antibody
See all APOBEC3G products (6) ...

Description

Rabbit polyclonal to APOBEC3G

Tested applications

WB, ICC/IFmore details

Cross reactivity

Reacts with

Human

Immunogen

Synthetic peptide: CPFQPWDGLDEHSQDLSGRLRAILQNQEN, corresponding to amino acids 356-384 of Human APOBEC3G

CPFQPWDGLD EHSQDLSGRL RAILQNQEN

Properties

Form

Liquid

Storage instructions

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: None
Constituents: 50% Glycerol

Purity

Whole antiserum

Clonality

Polyclonal

Isotype

IgG

  • Immunocytochemistry/ Immunofluorescence - APOBEC3G antibody (ab54257)Immunocytochemistry/ Immunofluorescence - APOBEC3G antibody (ab54257) image (enlarge)

  • Western blot - APOBEC3G antibody (ab54257)Western blot - APOBEC3G antibody (ab54257) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab54257 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • ShowHide1 Image

    WB

     WB: Use a concentration ...Read more →

    WB: Use a concentration of 1 µg/mlDetects a band of approximately 42 kDa (predicted molecular weight: 46 kDa).

  • 1 Image

    ICC/IF

     ICC/IF: 1/250

    ICC/IF: 1/250

Target

Function

DNA deaminase (cytidine deaminase) that mediates a form of innate resistance to retroviral infections (at least to HIV-1 infection) by triggering G-to-A hypermutation in the newly synthesized viral DNA. The replacements C-to-U in the minus strand DNA of HIV-1 during reverse transcription, leads to G-to-A transitions in the plus strand. The inhibition of viral replication is either due to the degradation of the minus strand before its integration or to the lethality of the hypermutations. Modification of both DNA strands is not excluded. This antiviral activity is neutralized by the virion infectivity factor (VIF), that prevents the incorporation of APOBEC3G into progeny HIV-1 virions by both inhibiting its translation and/or by inducing its ubiquitination and subsequent degradation by the 26S proteasome. APOBEC3G binds a variety of RNAs, but does not display detectable APOB, NF1 and NAT1 mRNA editing.

Tissue specificity

Expressed in spleen, testes, ovary and peripheral blood leukocytes and CD4+ lymphocytes. Also expressed in non-permissive peripheral blood mononuclear cells, and several tumor cell lines; no expression detected in permissive lymphoid and non-lymphoid cell lines.

Sequence similarities

Belongs to the cytidine and deoxycytidylate deaminase family.

Post-translational
modifications

Ubiquitinated in the presence of HIV-1 VIF. Association with VIF targets the protein for proteolysis by the ubiquitin-dependent proteasome pathway.

Cellular localization

Cytoplasm. Nucleus. Mainly cytoplasmic. Small amount are found in the nucleus. During HIV-1 infection, virion-encapsidated in absence of HIV-1 VIF.

Target information above from: UniProt accessionQ9HC16 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • ABC3G_HUMAN antibody
  • APOBEC related cytidine deaminase antibody
  • APOBEC related protein antibody
  • APOBEC-related cytidine deaminase antibody
  • APOBEC-related protein 9 antibody
  • APOBEC-related protein antibody
  • APOBEC3G antibody
  • Apolipoprotein B mRNA editing enzyme catalytic polypeptide like 3G antibody
  • ARCD antibody
  • ARP-9 antibody
  • ARP9 antibody
  • bK150C2.7 antibody
  • CEM-15 antibody
  • CEM15 antibody
  • dJ494G10.1 antibody
  • DNA dC dU editing enzyme APOBEC 3G antibody
  • DNA dC->dU-editing enzyme APOBEC-3G antibody
  • EC 3.5.4. antibody
  • FLJ12740 antibody
  • MDS019 antibody
  • OTTHUMP00000028911 antibody
see all

Anti-APOBEC3G antibody images:

  Immunocytochemistry/ Immunofluorescence - APOBEC3G antibody (ab54257)

Immunocytochemistry/ Immunofluorescence - APOBEC3G antibody (ab54257)

HeLa cell monolayers were transfected with an APOBEC3G expression vector, fixed after 24 hr and hybridised with the anti-APOBEC3G ab54257 (1/500 dilution). Bound antibody was detected using an Alexa Fluor 594-conjugated goat secondary antibody and imaged by confocal microscopy. APOBEC3G is seen (in green) distributed throughout the cytosol, and concentrated in small areas called P-bodies.

  Western blot - APOBEC3G antibody (ab54257)

Western blot - APOBEC3G antibody (ab54257)

All lanes : Anti-APOBEC3G antibody (ab54257) at 1/500 dilution

Lane 1 : Spleen (Human) Tissue Lysate - adult normal tissue (ab29699)
Lane 2 : Testis (Human) Tissue Lysate - adult normal tissue (ab30257)
Lane 3 : Ovary (Human) Tissue Lysate - adult normal tissue (ab30222)
Lane 4 : Jurkat (Human T cell lymphoblast-like cell line) Whole Cell Lysate

Lysates/proteins at 10 µg per lane.

Secondary
Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution
developed using the ECL technique

Performed under reducing conditions.

Predicted band size : 46 kDa
Observed band size : 42 kDa (why is the actual band size different from the predicted?)
Additional bands at : 36 kDa,70 kDa. We are unsure as to the identity of these extra bands.

Exposure time : 8 minutes

References for Anti-APOBEC3G antibody (ab54257)

This product has been referenced in:

  • Gallois-Montbrun Set al. Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules. J Virol 81:2165-78 (2007).Read more (PubMed: 17166910) »

See 1 publication for this product

Publishing research using ab54257? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"